Xu Zhenyu 4

What Happened

• Zhenyu Xu, Chief Scientific Officer of SOPHiA GENETICS SA, sold 4,000 shares on July 13, 2026. The filing reports a weighted average sale price of $5.70 per share for total proceeds of $22,819. The sale was reported as an open-market or private sale (Code S).

Key Details

• Transaction date: 2026-07-13
• Price: weighted average $5.70; shares were sold in multiple transactions at prices ranging from $5.54 to $5.79 (footnote)
• Proceeds: $22,819 (approx.)
• Shares owned after transaction: not disclosed in the provided filing
• Notable footnotes: F1 — sale made pursuant to a duly adopted Rule 10b5-1(c) trading plan; F2 — price shown is a weighted average and the filer will provide per-price breakdown on written request
• Filing timeliness: Form filed 2026-07-14 (one day after the trade); this appears timely under Form 4 reporting rules

Context

• The sale was executed under a 10b5-1 trading plan, which typically authorizes pre-set trades and can mean the sale was scheduled in advance rather than a real-time signal about the insider’s view. Sales are common for insiders for liquidity or diversification; they are not by themselves proof of company outlook.